News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alnara Pharmaceuticals, Inc. Flourishes from Altus Pharmaceuticals Inc. (ALTU) Demise



3/5/2010 7:17:45 AM

Mass High Tech -- Alnara Pharmaceuticals Inc. stands ready to send its drug target to treat cystic fibrosis to the U.S. Food and Drug Administration, a mere 16 months after the company raised its first venture capital round of $20 million.

Read at Mass High Tech


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES